- GOGOA AND SCIENCE -

Gogoa participates in clinical trials and studies proactively to demonstrate the clinical efficacy and safety of medical devices.

You can see the pre-post-marketing studies carried out with Gogoa's medical devices in important reference centers and hospitals.

"The developed exoskeleton enables longitudinal overground training of walking in hemiparetic patients after stroke. Opens the opportunity to study means to optimize a rehabilitation treatment that can be customized for individuals."

 

Clinical trial conducted with the HANK (H2) precursor exoskeleton at TIRR Memorial (Houston, Texas) with stroke patients. The objective was to evaluate the safety and usability of the medical device.

Hank usability case study.PNG
Ensayo clinico 1.JPG

"The developed exoskeleton enables longitudinal overground training of walking in hemiparetic patients after stroke. Opens the opportunity to study means to optimize a rehabilitation treatment that can be customized for individuals."

 

Clinical trial conducted with the HANK (H2) precursor exoskeleton at TIRR Memorial (Houston, Texas) with stroke patients. The objective was to evaluate the safety and usability of the medical device.

Próximamente.JPG

Safety and changes in gait function after treatment with HANK ambulatory robotic exoskeleton in incomplete spinal cord injury patients.

Clinical trial under review conducted at the Paraplegic Hospital of Toledo to investigate the safety and viability of the HANK exoskeleton and to assess changes in gait pattern compared to a control group.

Próximamente.JPG

Controlled, randomized, multicenter clinical trial to demonstrate the functional and clinical applicability of the BELK device in the rehabilitation process.

Clinical trial with knee arthroplasty patients in the initial phase, which will be carried out at Cruces University Hospital and Araba University Hospital.